1. Home
  2. MDGL vs LLYVA Comparison

MDGL vs LLYVA Comparison

Compare MDGL & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • LLYVA
  • Stock Information
  • Founded
  • MDGL 2011
  • LLYVA 1991
  • Country
  • MDGL United States
  • LLYVA United States
  • Employees
  • MDGL N/A
  • LLYVA N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • LLYVA Broadcasting
  • Sector
  • MDGL Health Care
  • LLYVA Industrials
  • Exchange
  • MDGL Nasdaq
  • LLYVA Nasdaq
  • Market Cap
  • MDGL 6.8B
  • LLYVA 6.8B
  • IPO Year
  • MDGL N/A
  • LLYVA N/A
  • Fundamental
  • Price
  • MDGL $277.24
  • LLYVA $75.55
  • Analyst Decision
  • MDGL Strong Buy
  • LLYVA
  • Analyst Count
  • MDGL 10
  • LLYVA 0
  • Target Price
  • MDGL $420.63
  • LLYVA N/A
  • AVG Volume (30 Days)
  • MDGL 360.1K
  • LLYVA 114.4K
  • Earning Date
  • MDGL 05-01-2025
  • LLYVA 01-01-0001
  • Dividend Yield
  • MDGL N/A
  • LLYVA N/A
  • EPS Growth
  • MDGL N/A
  • LLYVA N/A
  • EPS
  • MDGL N/A
  • LLYVA 0.27
  • Revenue
  • MDGL $317,383,000.00
  • LLYVA N/A
  • Revenue This Year
  • MDGL $285.43
  • LLYVA $7.29
  • Revenue Next Year
  • MDGL $63.77
  • LLYVA N/A
  • P/E Ratio
  • MDGL N/A
  • LLYVA $283.38
  • Revenue Growth
  • MDGL N/A
  • LLYVA N/A
  • 52 Week Low
  • MDGL $200.63
  • LLYVA $32.55
  • 52 Week High
  • MDGL $377.46
  • LLYVA $79.63
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 35.37
  • LLYVA 58.63
  • Support Level
  • MDGL $281.76
  • LLYVA $72.41
  • Resistance Level
  • MDGL $295.60
  • LLYVA $78.43
  • Average True Range (ATR)
  • MDGL 13.97
  • LLYVA 1.95
  • MACD
  • MDGL -1.69
  • LLYVA 0.13
  • Stochastic Oscillator
  • MDGL 8.89
  • LLYVA 67.60

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

Share on Social Networks: